Regulation of Calcium Homeostasis by MyomiRs in Heart Failure
心力衰竭中 MyomiRs 对钙稳态的调节
基本信息
- 批准号:9172660
- 负责人:
- 金额:$ 39.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-11-14 至 2019-10-31
- 项目状态:已结题
- 来源:
- 关键词:AdultArrhythmiaBase PairingCa(2+)-Transporting ATPaseCalciumCalmodulinCardiacCardiac MyocytesCellsCharacteristicsCodeComplexCouplingCyclic AMP-Dependent Protein KinasesDevelopmentElectrophysiology (science)EnzymesExperimental ModelsFamilyFunctional disorderGene ExpressionGenesGenetic TranscriptionHeartHeart DiseasesHeart failureHomeostasisHumanHypertrophyImageIn VitroInbred SHR RatsIntronsInvestigationLaser Scanning Confocal MicroscopyMacromolecular ComplexesMalignant - descriptorMediatingMessenger RNAMicroRNAsModelingMolecularMuscleMuscle CellsMyosin Heavy ChainsNucleotidesPathogenesisPathologyPatternPhenotypePhosphorylationPhotonsPlayPoriferaPost-Translational Protein ProcessingProcessProtein phosphataseProteinsRattusRegulationRegulator GenesRoleRyanodine Receptor Calcium Release ChannelRyanodine ReceptorsSarcoplasmic ReticulumStructureTechniquesTestingTherapeuticTissuesTranscriptTranslational RepressionTranslationsUntranslated RNAVentricularWorkbasecalcineurin phosphatasecardiogenesisin vivoinsightmortalitynovelphosphodiesterase 4Dpri-miRNAprotein functionpublic health relevancesudden cardiac deathtargeted treatment
项目摘要
DESCRIPTION (provided by applicant): Despite advances in the understanding of underlying mechanisms, heart failure (HF) remains the major cause of mortality, indicating the urgent need in the development of novel unconventional therapeutic strategies. Abnormal intracellular calcium (Ca2+) handling has been implicated in the pathogenesis of malignant arrhythmias characteristic of Heart Failure (HF). Cardiac excitation-contraction (EC) coupling is mediated through Ca2+-induced Ca2+ release (CICR), which is controlled by sarcoplasmic reticulum (SR) Ca2+-sensitive Ca2+ channels, also known as cardiac ryanodine receptors (RyR2). MicroRNAs (miRs) are ~22-nucleotide-long nonprotein-coding RNAs that recognize their target mRNAs by base pairing interactions and subsequently inhibit gene expression by targeting these mRNAs for translational repression or degradation. Rapidly accumulating evidence implicates dysregulated miRs in cardiac pathogenesis including arrhythmias and HF rendering them new attractive targets for therapy. However, much work must be done for better understanding of miR functions. Our preliminary results implicate a family of miRs specific to muscle tissue called myomiRs in regulation of Ca2+ handling in cardiomyocytes. The central hypothesis of this proposal is that myomiRs which include miR-208a, miR-208b and miR-499 play a critical role in regulating Ca2+ homeostasis by modulating the structure and function of macromolecular complexes involved in Ca2+ handling. In order to test this hypothesis we have developed techniques to modify the expression of miRNAs in vitro and in intact hearts in vivo in order to examine their effects on Ca2+ cycling in single ventricular myocytes using electrophysiology and single photon laser scanning confocal microscopy. Specifically we aim to investigate the molecular determinants of myomiR-mediated regulation of SR Ca2+ release through RyR2s in ventricular myocytes, and test whether aberrant expression patterns of these miRs contribute to Ca2+-dependent arrhythmias characteristic of cardiac disease using rat model of heart failure.
描述(由申请人提供):尽管在对潜在机制的理解方面取得了进展,但心力衰竭(HF)仍然是死亡的主要原因,这表明迫切需要开发新的非常规治疗策略。细胞内钙(Ca 2+)处理异常与心力衰竭(HF)特征性恶性心律失常的发病机制有关。心脏兴奋-收缩(EC)偶联通过Ca 2+诱导的Ca 2+释放(CICR)介导,CICR由肌浆网(SR)Ca 2+敏感性Ca 2+通道(也称为心脏ryanodine受体(RyR 2))控制。微小RNA(microRNAs,miRs)是一种长度约为22个核苷酸的非蛋白质编码RNA,通过碱基配对相互作用识别靶mRNA,随后通过靶向这些mRNA进行翻译抑制或降解来抑制基因表达。快速积累的证据表明miR在心脏发病机制中的失调,包括心律失常和HF,使其成为新的有吸引力的治疗靶点。然而,为了更好地理解miR的功能,还必须做很多工作。我们的初步研究结果表明,一个家族的miR特异性肌肉组织称为myomiRs在调节心肌细胞中的Ca 2+处理。该提议的中心假设是,包括miR-208 a、miR-208 b和miR-499的myomiR通过调节参与Ca 2+处理的大分子复合物的结构和功能在调节Ca 2+稳态中起关键作用。为了验证这一假设,我们已经开发了技术,以修改在体外和在完整的心脏在体内的表达的miRNA,以检查其对Ca 2+循环在单个心室肌细胞的电生理学和单光子激光扫描共聚焦显微镜的影响。具体而言,我们的目的是研究myomiR介导的调节SR钙释放的分子决定因素,通过RyR 2s在心室肌细胞,并测试这些miR的异常表达模式是否有助于Ca 2+依赖性心律失常的心脏疾病的特征,使用大鼠模型的心力衰竭。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dmitry A Terentyev其他文献
Dmitry A Terentyev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dmitry A Terentyev', 18)}}的其他基金
The mechanisms and roles of mitochondria dysfunction in cardiac arrhythmogenesis
线粒体功能障碍在心律失常发生中的机制和作用
- 批准号:
10734432 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Defining the role of KCNN1 in atrial arrhythmias
定义 KCNN1 在房性心律失常中的作用
- 批准号:
10666164 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Novel Mechanisms of Regulation of SK channels: Implications for Cardiac Arrhythmia
SK 通道调节的新机制:对心律失常的影响
- 批准号:
10161846 - 财政年份:2019
- 资助金额:
$ 39.75万 - 项目类别:
Novel Mechanisms of Regulation of SK channels: Implications for Cardiac Arrhythmia
SK 通道调节的新机制:对心律失常的影响
- 批准号:
10424495 - 财政年份:2019
- 资助金额:
$ 39.75万 - 项目类别:
Regulation of Calcium Homeostasis by MyomiRs in Heart Failure
心力衰竭中 MyomiRs 对钙稳态的调节
- 批准号:
8962163 - 财政年份:2014
- 资助金额:
$ 39.75万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
WBP Fellowship
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 39.75万 - 项目类别:














{{item.name}}会员




